B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATP12A

MOLECULAR TARGET

ATPase H+/K+ transporting non-gastric alpha2 subunit

UniProt: P54707NCBI Gene: 4791 compounds

ATP12A (ATPase H+/K+ transporting non-gastric alpha2 subunit) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATP12A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.0.691

About ATP12A as a Drug Target

ATP12A (ATPase H+/K+ transporting non-gastric alpha2 subunit) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented ATP12A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATP12A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.